Chemotherapy

New drug targets tumour defences and reverses chemotherapy resistance

Researchers at King’s College London have developed a novel daily pill, KCL‑HO‑1i, that turns off tumour‑guarding macrophages and boosts chemotherapy effectiveness.

Need for supportive care in oncology will increase during the next decade

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic...

Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid...

Acute myeloid leukaemia (AML)

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form...

Living with Leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is...

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Tumour-host interactions, paediatric sarcomas, and cancer progression

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders